08.02.2024 - - Award Recognizes Approval of Amicus Therapeutics’ Two-component Therapy for the Treatment of Late-onset Pompe Disease -PRINCETON, N.J., Feb. 08, 2024 (GLOBE NEWSWIRE) - Amicus Therapeutics (Nasdaq: FOLD), today announced that WORLDSymposium has . Seite 1
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2022 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders - read this article along with other careers information, tips and advice on BioSpace
JCR Pharmaceuticals Receives the WORLDSymposium™ New Treatment Award for IZCARGO® (Pabinafusp Alfa) - read this article along with other careers information, tips and advice on BioSpace